J&J Report Pins Manufacturing Woes on Acquisition as Pharma Ups M&A

Johnson & Johnson’s (J&J) ongoing manufacturing issues can largely be pinned on mistakes made during its Pfizer Consumer Healthcare (PCH) acquisition, a special J&J committee says — just as pharma execs predict a slew of M&A activity over the next two years.
Drug GMP Report